Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024724 · ClinicalTrials.gov registry record · Phase 4

Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain

A Phase 4 study, sponsored by Northwestern University.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target

NCT02024724 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024724, a Phase 4 study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target

Study Summary

Trigeminal neuralgia is a craniofacial pain syndrome that is typically characterized by unilateral severe, recurrent, electrical pain in one or more distributions of the trigeminal nerve. Current treatment strategies include oral medications as first line therapy with surgical interventions reserved for those patients who are refractory to medications or unable to tolerate medication side effects. Despite these current treatment options, many patients continue to have symptoms. Ultrasound-guided trigeminal nerve block allows for fine adjustment of the needle tip and direct observation of the medicine. Local anesthetic and steroids have been successfully used for diagnostic and or therapeutic nerve pain with great success. Steroids can be short or long acting in duration with varying side effects. If there exists a difference in duration of action, using the longer acting drug will provide a greater period of symptom relief for the patient and may allow the patient to undergo fewer interventional procedures.

Interventions

  • DRUG Bupivacaine
  • DRUG Dexamethasone
  • DRUG Triamcinolone

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-11
Est. Completion 2017-03
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT02024724

The ClinicalTrials.gov registry entry for NCT02024724 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.

NCT02024724 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02024724 about?

NCT02024724 is a clinical study titled "Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain". Trigeminal neuralgia is a craniofacial pain syndrome that is typically characterized by unilateral severe, recurrent, electrical pain in one or more distributions of the trigeminal nerve. Current treatment strategies include oral medications as first line therapy with surgical interventions reserved...

What is the current status of trial NCT02024724?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-11. Estimated completion is 2017-03.

What interventions are being tested in trial NCT02024724?

The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), Triamcinolone (DRUG).

Who is sponsoring clinical trial NCT02024724?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.